Prelude Capital Management, LLC Charles River Laboratories International, Inc. Transaction History

Prelude Capital Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$206.39 - $268.73 $719,681 - $937,061	-3,487 Reduced 51.72%	3,255 $672,000
Q1 2024 May 15, 2024	BUY	$203.52 - $273.43 $297,953 - $400,301	1,464 Added 27.74%	6,742 $1.83 Million
Q4 2023 Feb 14, 2024	BUY	$164.52 - $238.84 $868,336 - $1.26 Million	5,278 New	5,278 $1.25 Million
Q4 2022 Feb 14, 2023	BUY	$197.11 - $250.07 $433,050 - $549,403	2,197 Added 211.66%	3,235 $704,000
Q3 2022 Nov 14, 2022	SELL	$182.44 - $250.54 $36,123 - $49,606	-198 Reduced 16.02%	1,038 $204,000
Q2 2022 Aug 15, 2022	SELL	$204.13 - $302.4 $266,389 - $394,631	-1,305 Reduced 51.36%	1,236 $264,000
Q1 2022 May 16, 2022	BUY	$255.51 - $362.11 $649,250 - $920,121	2,541 New	2,541 $722,000
Q2 2019 Aug 14, 2019	SELL	$123.4 - $148.55 $6,910 - $8,318	-56 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$105.09 - $137.23 $5,885 - $7,684	56 New	56 $6,000
Q4 2017 Feb 14, 2018	SELL	$100.43 - $118.09 $305,206 - $358,875	-3,039 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$96.72 - $109.26 $293,932 - $332,041	3,039	3,039 $328,000

696

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.56B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.